News

Cethrin, a recombinant protein-based inhibitor of Rho signaling, is co-delivered with a fibrin sealant and administered once directly onto the surface of the spinal cord during spinal decompression

Although doctors have known that the cervical tissue at the opening to the womb can harbor multiple human papillomavirus (HPV) types, this study is the first to document

The filing is based on impressive phase III trial data, which show that the addition of Avastin to standard chemotherapy as a primary treatment for advanced breast cancer

The State Food and Drug Administration (SFDA)’s implementation plan requires that provincial drug regulatory departments carry out a full investigation of manufacturers of drug raw materials and drug

In an approvable letter to the company the FDA indicated that the agency required an additional study because it believed the results of the three trials conducted to

The amendment of their merger agreement of March 12, 2006 sees the deadline to close the transaction extended from September 12, 2006 until November 13, 2006. The amendment

As a result of a recent meeting with the FDA, the companies announced that they would re-submit an amended application seeking approval for RSD1235. Under terms of the

QS-21 is the leading member of the Stimulon family of adjuvants developed by Antigenics, and has been shown to stimulate both antibody as well as cellular immune responses.

Researchers at the UK’s Drug Safety Research Unit and University of Portsmouth analyzed prescribing data for 11,185 patients seen by NHS family doctors. The data was gathered from